Guangdong Biolight Hits Day High with 7.86% Surge in Stock Price

Guangdong Biolight Meditech Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.86% on March 10, 2026. The stock reached an intraday high of CNY 14.30, reflecting a strong day of trading for the small-cap company in the Pharmaceuticals & Biotechnology sector. In terms of performance metrics, Guangdong Biolight has shown a remarkable 89.45% increase over the past year, significantly outperforming the China Shanghai Composite, which recorded a 22.49% gain during the same period. Year-to-date, the stock has risen by 72.84%, further highlighting its recent momentum. Despite these positive short-term trends, the company has faced challenges in long-term growth, with net sales declining at an annual rate of 4.48% over the last five years. Additionally, the operating profit has seen a substantial decrease of 173.40%. The stock's current market capitalization stands at CNY 2,751 million, with a dividend yield of 0.48%. As the company navigates its financial landscape, these performance indicators provide a snapshot of its current standing in the market.